Severe febrile respiratory illnesses as a cause of mass critical care

Christian E Sandrock1

  • 1Division of Pulmonary and Critical Care, University of California Davis School of Medicine, 4150 V Street, #3400, Sacramento CA 95817, USA. cesandrock@ucdavis.edu

Respiratory Care
|January 5, 2008
PubMed

Insights

Rare, contagious agents causing febrile respiratory illnesses can lead to epidemics, straining healthcare systems. Early recognition and infection control are vital for managing these severe respiratory failure cases.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • Febrile respiratory illnesses with respiratory failure are common ICU admissions, often caused by community-acquired pneumonia.
  • Rare, highly contagious agents can present similarly, posing epidemic risks with significant healthcare system impact.

Purpose of the Study:

  • To outline key rare and contagious agents causing febrile respiratory illnesses that can lead to epidemics.
  • To emphasize the importance of epidemiological clues in recognizing these agents.
  • To discuss management strategies and infection control measures.

Main Methods:

  • Review of epidemiological and clinical characteristics of epidemic-potential febrile respiratory pathogens.
  • Discussion of diagnostic approaches and treatment modalities, including supportive care and ventilation.
  • Emphasis on infection control protocols, including personal protective equipment (PPE).

Main Results:

  • Identified key epidemic-causing agents: influenza, SARS-associated coronavirus, smallpox, viral hemorrhagic fever, plague, tularemia, and anthrax.
  • Highlighted the critical role of epidemiological assessment in early identification.
  • Stressed the need for lung-protective ventilation and stringent infection control to prevent transmission.

Conclusions:

  • Early recognition of rare febrile respiratory illness agents is crucial for epidemic prevention.
  • Effective management involves prompt diagnosis, appropriate treatment (antibiotics, antivirals, supportive care), and lung-protective ventilation.
  • Strict adherence to infection control measures and use of appropriate PPE are essential to protect healthcare workers and patients.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...